Find Grants for Non-profits

Find Out If You Qualify for Verified Grants! Discover your eligibility and access 1,903 verified grants for nonprofits, small businesses, startups, and individuals from trusted foundations and government sources.

Total Dollar Available
$ 100 Trillion

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

Deadline: December 3, 2027


Opportunity Number: RFA-DA-26-055

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: December 3, 2027

Status: Posted

CFDA Numbers: 93.273, 93.279

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

Deadline: December 3, 2027


Opportunity Number: RFA-DA-26-056

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: December 3, 2027

Status: Posted

CFDA Numbers: 93.273, 93.279

Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-299

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.273, 93.307, 93.399

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

Deadline: January 7, 2027


Opportunity Number: PAR-25-025

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.838, 93.839, 93.233, 93.837

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

Deadline: January 7, 2027


Opportunity Number: PAR-25-026

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.840, 93.233, 93.839, 93.837, 93.838

NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)

Deadline: May 7, 2026


Opportunity Number: PAR-25-239

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.121

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Deadline: November 5, 2027


Opportunity Number: PAR-25-297

Agency: National Institutes of Health

Open Date: December 4, 2024

Close Date: November 5, 2027

Status: Posted

CFDA Numbers: 93.866

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)

Deadline: March 20, 2026


Opportunity Number: PAR-25-242

Agency: National Institutes of Health

Open Date: December 4, 2024

Close Date: March 20, 2026

Status: Posted

CFDA Numbers: 93.313, 93.173, 93.865, 93.989, 93.242, 93.399, 93.853, 93.286, 93.867

Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)

Deadline: January 7, 2027


Opportunity Number: PAR-25-310

Agency: National Institutes of Health

Open Date: December 3, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.242

NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-251

Agency: National Institutes of Health

Open Date: December 3, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.855

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)

Deadline: November 12, 2027


Opportunity Number: PAR-25-215

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: November 12, 2027

Status: Posted

CFDA Numbers: 93.853

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)

Deadline: November 12, 2027


Opportunity Number: PAR-25-216

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: November 12, 2027

Status: Posted

CFDA Numbers: 93.853

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

Deadline: November 16, 2027


Opportunity Number: PAR-25-265

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: November 16, 2027

Status: Posted

CFDA Numbers: 93.865

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

Deadline: November 16, 2027


Opportunity Number: PAR-25-266

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: November 16, 2027

Status: Posted

CFDA Numbers: 93.865

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

Deadline: November 13, 2026


Opportunity Number: PAR-25-270

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: November 13, 2026

Status: Posted

CFDA Numbers: 93.213

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

Deadline: November 13, 2026


Opportunity Number: PAR-25-269

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: November 13, 2026

Status: Posted

CFDA Numbers: 93.213

NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

Deadline: November 13, 2026


Opportunity Number: PAR-25-271

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: November 13, 2026

Status: Posted

CFDA Numbers: 93.213

NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Deadline: January 6, 2028


Opportunity Number: PAR-25-188

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: January 6, 2028

Status: Posted

CFDA Numbers: 93.121

Alcohol Health Services Research (R01 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PA-25-245

Agency: National Institutes of Health

Open Date: November 27, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.273

Alcohol Health Services Research (R34 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PAR-25-192

Agency: National Institutes of Health

Open Date: November 27, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.273

Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)

Deadline: September 7, 2026


Opportunity Number: PA-25-163

Agency: National Institutes of Health

Open Date: November 27, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.273

Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)

Deadline: September 7, 2026


Opportunity Number: PAR-25-193

Agency: National Institutes of Health

Open Date: November 27, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.273

Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)

Deadline: October 15, 2027


Opportunity Number: PAR-25-179

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)

Deadline: October 15, 2027


Opportunity Number: PAR-25-181

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)

Deadline: October 15, 2027


Opportunity Number: PAR-25-182

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242